Ann Dermatol.  2011 Dec;23(Suppl 3):S380-S382. 10.5021/ad.2011.23.S3.S380.

A Case of Celecoxib Induced Acute Generalized Exanthematous Pustulosis

Affiliations
  • 1Department of Dermatology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. dylee@skku.edu

Abstract

Acute generalized exanthematous pustulosis (AGEP) is manifested by rapid development of many sterile, nonfollicular pustules on a background of edematous erythema. More than 90 percent of AGEP are induced by medication, mostly antibiotics. Drug patch test can be helpful in the diagnosis of AGEP. This paper reports the first case of celecoxib-induced AGEP confirmed by patch test in Korean literature.

Keyword

Acute generalized exanthematous pustulosis; Celecoxib; Patch test

MeSH Terms

Acute Generalized Exanthematous Pustulosis
Anti-Bacterial Agents
Erythema
Patch Tests
Pyrazoles
Sulfonamides
Celecoxib
Anti-Bacterial Agents
Pyrazoles
Sulfonamides

Figure

  • Fig. 1 (A) Numerous tiny nonfollicular pustules on the face. (B) A hundred of non-follicular pustules on the back.

  • Fig. 2 (A) Subconeal pustules in the epidermis (H&E, ×200). (B) Perivascular infiltration of lymphocytes and eosinophils in the upper dermis (H&E, ×400).

  • Fig. 3 Strong vesicular reaction to celecoxib diluted at 5% in normal saline after 48 hours.


Reference

1. Sidoroff A, Halevy S, Bavinck JN, Vaillant L, Roujeau JC. Acute generalized exanthematous pustulosis (AGEP)--a clinical reaction pattern. J Cutan Pathol. 2001. 28:113–119.
Article
2. Mashiah J, Brenner S. A systemic reaction to patch testing for the evaluation of acute generalized exanthematous pustulosis. Arch Dermatol. 2003. 139:1181–1183.
Article
3. Choi MJ, Kim HS, Park HJ, Park CJ, Lee JD, Lee JY, et al. Clinicopathologic manifestations of 36 korean patients with acute generalized exanthematous pustulosis: a case series and review of the literature. Ann Dermatol. 2010. 22:163–169.
Article
4. Britschgi M, Steiner UC, Schmid S, Depta JP, Senti G, Bircher A, et al. T-cell involvement in drug-induced acute generalized exanthematous pustulosis. J Clin Invest. 2001. 107:1433–1441.
Article
5. Goeschke B, Braathen LR. Acute generalized exanthematic pustulosis: a case and an overview of side effects affecting the skin caused by celecoxib and other COX-2 inhibitors reported so far. Dermatology. 2004. 209:53–56.
Article
6. Yang CC, Lee JY, Chen WC. Acute generalized exanthematous pustulosis caused by celecoxib. J Formos Med Assoc. 2004. 103:555–557.
7. Baker H, Ryan TJ. Generalized pustular psoriasis. A clinical and epidemiological study of 104 cases. Br J Dermatol. 1968. 80:771–793.
8. Beylot C, Bioulac P, Doutre MS. Acute generalized exanthematic pustuloses (four cases) (author's transl). Ann Dermatol Venereol. 1980. 107:37–48.
9. Barbaud A. Drug patch testing in systemic cutaneous drug allergy. Toxicology. 2005. 209:209–216.
Article
Full Text Links
  • AD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr